These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22175869)

  • 1. Preliminary web-based measures development for GHB: expectancies, functions, and withdrawal.
    Stein LA; Lebeau R; Clair M; Martin R; Bryant M; Storti S
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):121-9. PubMed ID: 22175869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A web-based study of gamma hydroxybutyrate (GHB): patterns, experiences, and functions of use.
    Stein LA; Lebeau R; Clair M; Martin R; Bryant M; Storti S; Monti P
    Am J Addict; 2011; 20(1):30-9. PubMed ID: 21175918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
    Liao PC; Chang HM; Chen LY
    J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal.
    Miotto K; Darakjian J; Basch J; Murray S; Zogg J; Rawson R
    Am J Addict; 2001; 10(3):232-41. PubMed ID: 11579621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
    McDaniel CH; Miotto KA
    J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-hydroxybutyrate withdrawal syndrome.
    Dyer JE; Roth B; Hyma BA
    Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GHB withdrawal delirium].
    Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
    Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.
    Wojtowicz JM; Yarema MC; Wax PM
    CJEM; 2008 Jan; 10(1):69-74. PubMed ID: 18226321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gamma-hydroxybutyrate withdrawal syndrome.
    Tarabar AF; Nelson LS
    Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid.
    Hernandez M; McDaniel CH; Costanza CD; Hernandez OJ
    Am J Drug Alcohol Abuse; 1998 Feb; 24(1):179-83. PubMed ID: 9513637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
    van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
    Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review.
    Siefried KJ; Freeman G; Roberts DM; Lindsey R; Rodgers C; Ezard N; Brett J
    Psychopharmacology (Berl); 2023 Jan; 240(1):127-135. PubMed ID: 36508055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.
    van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA
    Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inpatient management of GHB/GBL withdrawal.
    Delic M
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):354-356. PubMed ID: 31488752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups.
    Brennan R; Van Hout MC
    J Psychoactive Drugs; 2014; 46(3):243-51. PubMed ID: 25052883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review.
    Craig K; Gomez HF; McManus JL; Bania TC
    J Emerg Med; 2000 Jan; 18(1):65-70. PubMed ID: 10645841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report.
    Glasper A; McDonough M; Bearn J
    Eur Addict Res; 2005; 11(3):152-4. PubMed ID: 15990433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
    Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
    McDonough M; Kennedy N; Glasper A; Bearn J
    Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.